Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 7:32 PM UTC
| NCT Number | NCT05061550 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE2 |
| Target Enrollment | 630 participants |
| Active Locations | 25 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | June 23, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT05061550 is currently recruiting participants. This phase2 study for lung cancer is actively seeking new participants at 25 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05061550 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05061550 was last updated 3 weeks ago (June 23, 2026). HelloStudys verifies this status automatically.